Comment on

• Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients.

  Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ. Reah G, et al. Crit Care Med. 1997 Sep;25(9):1480-8. doi: 10.1097/00003246-199709000-00014. Crit Care Med. 1997. PMID: 9295821 Clinical Trial.
• Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice.

  Su D, Roth RI, Levin J. Su D, et al. Crit Care Med. 1999 Apr;27(4):771-8. doi: 10.1097/00003246-199904000-00034. Crit Care Med. 1999. PMID: 10321668
• Diaspirin cross-linked hemoglobin improves mucosal perfusion in the ileum of septic rats.

  Sielenkämper AW, Eichelbrönner O, Martin CM, Madorin SW, Chin-Yee IH, Sibbald WJ. Sielenkämper AW, et al. Crit Care Med. 2000 Mar;28(3):782-7. doi: 10.1097/00003246-200003000-00029. Crit Care Med. 2000. PMID: 10752830